Differences in the frequency of macrophage and T cell markers between focal and crescentic classes of anti-neutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis

Dana Kidder ¹ * , Susan E Bray ², Stewart Fleming ³

Cited by CrossRef: 8

1- Nozaki Y. New Insights Into Novel Therapeutic Targets in ANCA-Associated Vasculitis. Front Immunol. 2021;12 [Crossref]

2- Martinez Valenzuela L, Bordignon Draibe J, Fulladosa Oliveras X, Bestard Matamoros O, Cruzado Garrit J, Torras Ambrós J. T-lymphocyte in ANCA-associated vasculitis: what do we know? A pathophysiological and therapeutic approach. 2019;12(4):503 [Crossref]

3- Reitsema R, Boots A, van der Geest K, Sandovici M, Heeringa P, Brouwer E. CD8+ T Cells in GCA and GPA: Bystanders or Active Contributors?. Front Immunol. 2021;12 [Crossref]

4- Chen A, Lee K, Guan T, He J, Schlondorff D. Role of CD8+ T cells in crescentic glomerulonephritis. 2020;35(4):564 [Crossref]

5- Pfenning M, Schmitz J, Scheffner I, Schulte K, Khalifa A, Tezval H, Weidemann A, Kulschewski A, Kunzendorf U, Dietrich S, Haller H, Kielstein J, Gwinner W, Bräsen J. High Macrophage Densities in Native Kidney Biopsies Correlate With Renal Dysfunction and Promote ESRD. Kidney International Reports. 2023;8(2):341 [Crossref]

6- Ishikawa Y, Tokutsu K, Nakayamada S, Kuchiba A, Fushimi K, Matsuda S, Tanaka Y. Short-term effectiveness and safety of rituximab versus cyclophosphamide for life-threatening ANCA-associated vasculitis: a propensity score analysis of the real-world nationwide database. Ann Rheum Dis. 2024;83(1):103 [Crossref]

7- Scurt F, Bose K, Hammoud B, Brandt S, Bernhardt A, Gross C, Mertens P, Chatzikyrkou C. Old known and possible new biomarkers of ANCA-associated vasculitis. Journal of Autoimmunity. 2022;133:102953 [Crossref]

8- Liao Z, Tang J, Luo L, Deng S, Luo L, Wang F, Yuan X, Hu X, Feng J, Li X. Altered circulating CCR6+and CXCR3+ T cell subsets are associated with poor renal prognosis in MPO-ANCA-associated vasculitis. Arthritis Res Ther. 2021;23(1) [Crossref]